ALEXZA PHARMACEUTICALS INC's ticker is ALXA and the CUSIP is 015384209. A total of 42 filers reported holding ALEXZA PHARMACEUTICALS INC in Q2 2014. The put-call ratio across all filers is 0.04 and the average weighting 2.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2014 | $976,000 | -51.1% | 213,472 | -52.6% | 0.02% | -52.6% |
| Q1 2014 | $1,996,000 | -11.5% | 450,638 | -5.5% | 0.04% | -9.5% |
| Q4 2013 | $2,255,000 | +25.3% | 476,645 | +35.6% | 0.04% | +20.0% |
| Q3 2013 | $1,800,000 | +68.2% | 351,473 | +42.6% | 0.04% | +59.1% |
| Q2 2013 | $1,070,000 | – | 246,473 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| LANSDOWNE PARTNERS AUSTRIA GMBH | 1,212,555 | $5,262,000 | 100.00% |
| HOWARD HUGHES MEDICAL INSTITUTE | 98,914 | $429,000 | 0.14% |
| Rotella Capital Management, Inc. | 10,000 | $43,000 | 0.14% |
| BBT Capital Management, LLC | 132,533 | $575,000 | 0.03% |
| Jefferies Group LLC | 477,500 | $2,072,000 | 0.02% |
| KENNEDY CAPITAL MANAGEMENT LLC | 246,473 | $1,070,000 | 0.02% |
| LANSDOWNE PARTNERS LIMITED PARTNERSHIP | 307,500 | $1,335,000 | 0.02% |
| FEDERATED HERMES, INC. | 674,300 | $2,926,000 | 0.01% |
| KNIGHT CAPITAL GROUP LLC | 61,466 | $265,000 | 0.01% |
| CREDIT SUISSE AG/ | 654,292 | $2,839,000 | 0.00% |